Your Cohort, home
ThornePortfolio monitoring
Fractional CFO by Your Cohort Powered by Decision OS

Lumen Specialty Pharmacy On track

Specialty pharmacy · Minority equity · $19.5M deployed · Last report Oct 5

Investor

Total Thorne capital in the company.
$19.5M
Minority equity stake
Thorne’s share of the company’s fair value at the last quarterly mark. New, added by Your Cohort
$19.0M
Ownership 41% · fair value
Annualized return on all cash in and out, with the open position at fair value. New, added by Your Cohort
18.9%
Since September 2024
(Cash returned + fair value) ÷ capital deployed. New, added by Your Cohort
1.31x
Returned + current value ÷ invested

Payments received

Payments received by Thorne
DateExpectedReceivedStatus
Oct 15$0.50M$0.50MPaid
Jul 15$0.50M$0.50MPaid
Apr 15$0.45M$0.45MPaid

Coming up

  • Quarterly dividend
    Jan 15
    ~$0.50M
  • Board meeting
    Dec 3
    Budget approval
  • Equity value update
    Dec 31
    Annual valuation

New marks a measure Your Cohort adds to Thorne’s reporting · fictional companies and figures · thresholds are placeholders · select or hover any dotted label for its definition